UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

HLA-DQA102:01 Is a Major Risk Factor for Lapatinib-Induced Hepatotoxicity in Women With Advanced Breast Cancer

Journal of clinical oncology, 2011-02, Vol.29 (6), p.667-673

2011

Volltextzugriff (PDF)

Phase III, Double-Blind, Randomized Study Comparing Lapatinib Plus Paclitaxel With Placebo Plus Paclitaxel As First-Line Treatment for Metastatic Breast Cancer

Journal of clinical oncology, 2008-12, Vol.26 (34), p.5544-5552

2008

Volltextzugriff (PDF)

Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer

Journal of clinical oncology, 2009-11, Vol.27 (33), p.5538-5546

2009

Volltextzugriff (PDF)

Efficacy and Safety of Lapatinib As First-Line Therapy for ErbB2-Amplified Locally Advanced or Metastatic Breast Cancer

Journal of clinical oncology, 2008-06, Vol.26 (18), p.2999-3005

2008

Volltextzugriff (PDF)

Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer

The New England journal of medicine, 2006-12, Vol.355 (26), p.2733-2743

2006

Volltextzugriff (PDF)

Development and Validation of an Improved Hardiness Measure: The Hardiness Resilience Gauge

European journal of psychological assessment : official organ of the European Association of Psychological Assessment, 2023-05, Vol.39 (3), p.222-239

2023

Volltextzugriff (PDF)

Modernizing Eligibility Criteria for Molecularly Driven Trials

Journal of clinical oncology, 2015-09, Vol.33 (25), p.2815-2820

2015

Volltextzugriff (PDF)

Drug Insight: intracellular inhibitors of HER2-clinical development of lapatinib in breast cancer

Nature clinical practice. Oncology, 2008-09, Vol.5 (9), p.512-520

2008

Volltextzugriff (PDF)

Lapatinib antitumor activity is not dependent upon phosphatase and tensin homologue deleted on chromosome 10 in ErbB2-overexpressing breast cancers

Cancer research (Chicago, Ill.), 2007-02, Vol.67 (3), p.1170-1175

2007

Volltextzugriff (PDF)

HER-2 Gene Amplification, HER-2 and Epidermal Growth Factor Receptor mRNA and Protein Expression, and Lapatinib Efficacy in Women with Metastatic Breast Cancer

Clinical cancer research, 2008-12, Vol.14 (23), p.7861-7870

2008

Volltextzugriff (PDF)

4(1H)-Quinolones with Liver Stage Activity against Plasmodium berghei

Antimicrobial Agents and Chemotherapy, 2013-01, Vol.57 (1), p.417-424

2013

Volltextzugriff (PDF)

Lapatinib plus capecitabine versus capecitabine alone for HER2+ (ErbB2+) metastatic breast cancer: quality-of-life assessment

Breast cancer research and treatment, 2009-10, Vol.117 (3), p.577-589

2009

Volltextzugriff (PDF)

Development of a Broad-Based Pollen Identification Dataset via Genomic and Image Analyses

Journal of allergy and clinical immunology, 2024-02, Vol.153 (2), p.AB110

2024

Volltextzugriff (PDF)

Emotional intelligence of leaders: a profile of top executives

Leadership & organization development journal, 2009-02, Vol.30 (1), p.87-101

2009

Volltextzugriff (PDF)

An Object Detection System for Identifying Pollen Species

Journal of allergy and clinical immunology, 2023-02, Vol.151 (2), p.AB83-AB83

2023

Volltextzugriff (PDF)

Update in oncology

Annals of internal medicine, 2004-09, Vol.141 (6), p.454

Stein, Steven H

2004

Volltextzugriff (PDF)

Update in oncology

Annals of internal medicine, 2003-10, Vol.139 (8), p.666

Stein, Steven H

2003

Volltextzugriff (PDF)

Interventional analytics in skilled nursing facilities associated with reduced readmissions

The American journal of managed care, 2024-05, Vol.30 (6 Spec No.), p.SP478-SP482

2024

Volltextzugriff (PDF)

Can the Purse Improve Radiology Results?

Emergency medicine news, 2009-10, Vol.31 (10), p.5-5

Stein, Steven H

2009

Volltextzugriff (PDF)

Can the Purse Improve Radiology Results?

Emergency medicine news, 2009-09, Vol.31 (9), p.31-51

Stein, Steven H

2009

Volltextzugriff (PDF)

A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses

Breast cancer research and treatment, 2008-12, Vol.112 (3), p.533-543

2008

Volltextzugriff (PDF)

Lapatinib in combination with capecitabine in the management of ErbB2-positive (HER2-positive) advanced breast cancer

Biologics, 2008-03, Vol.2 (1), p.61-65

Kaufman, Bella

2008

Volltextzugriff (PDF)

Risks and Safety of Advanced Therapies and Biologics in Inflammatory Bowel Disease: A Review for Nurses

Gastroenterology nursing, 2020-07, Vol.43 (4), p.E159-E171

2020

Volltextzugriff (PDF)

Signature program: a platform of basket trials

Oncotarget, 2018-04, Vol.9 (30), p.21383-21395

2018

Volltextzugriff (PDF)

1 – 25 von 1.739

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.513)
Mit Volltextzugriff
(1.420)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.046)
Life Sciences & Biomedicine
(904)
Humans
(796)
Female
(495)
Male
(448)
Biological And Medical Sciences
(313)
Middle Aged
(302)
Adult
(300)
Medical Sciences
(268)
Aged
(210)
Animals
(134)
Risk Factors
(131)
Psychiatry
(124)
Cardiovascular System & Cardiology
(112)
Social Sciences
(105)
Adolescent
(104)
Treatment Outcome
(100)
Cardiac & Cardiovascular Systems
(93)
General & Internal Medicine
(90)
Physical Sciences
(89)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

HLA-DQA102:01 Is a Major Risk Factor for Lapatinib-Induced Hepatotoxicity in Women With Advanced Breast Cancer

Phase III, Double-Blind, Randomized Study Comparing Lapatinib Plus Paclitaxel With Placebo Plus Paclitaxel As First-Line Treatment for Metastatic Breast Cancer

Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer

Efficacy and Safety of Lapatinib As First-Line Therapy for ErbB2-Amplified Locally Advanced or Metastatic Breast Cancer

Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer

Development and Validation of an Improved Hardiness Measure: The Hardiness Resilience Gauge

Modernizing Eligibility Criteria for Molecularly Driven Trials

Drug Insight: intracellular inhibitors of HER2-clinical development of lapatinib in breast cancer

Lapatinib antitumor activity is not dependent upon phosphatase and tensin homologue deleted on chromosome 10 in ErbB2-overexpressing breast cancers

HER-2 Gene Amplification, HER-2 and Epidermal Growth Factor Receptor mRNA and Protein Expression, and Lapatinib Efficacy in Women with Metastatic Breast Cancer

4(1H)-Quinolones with Liver Stage Activity against Plasmodium berghei

Lapatinib plus capecitabine versus capecitabine alone for HER2+ (ErbB2+) metastatic breast cancer: quality-of-life assessment

Development of a Broad-Based Pollen Identification Dataset via Genomic and Image Analyses

Emotional intelligence of leaders: a profile of top executives

An Object Detection System for Identifying Pollen Species

Repeatability and Reproducibility in Proteomic Identifications by Liquid Chromatography−Tandem Mass Spectrometry

Update in oncology

Update in oncology

Interventional analytics in skilled nursing facilities associated with reduced readmissions

Can the Purse Improve Radiology Results?

Can the Purse Improve Radiology Results?

A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses

Lapatinib in combination with capecitabine in the management of ErbB2-positive (HER2-positive) advanced breast cancer

Risks and Safety of Advanced Therapies and Biologics in Inflammatory Bowel Disease: A Review for Nurses

Signature program: a platform of basket trials

Suchergebnisse filtern